• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Omalizumab in chronic inducible urticaria: A real-life study of efficacy, safety, predictors of treatment outcome and time to response.

作者信息

Yu Miao, Terhorst-Molawi Dorothea, Altrichter Sabine, Hawro Tomasz, Chen Yu-Di, Liu Bo, Song Xiao-Ting, Zhao Zuo-Tao, Maurer Marcus

机构信息

Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.

Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.

出版信息

Clin Exp Allergy. 2021 May;51(5):730-734. doi: 10.1111/cea.13838. Epub 2021 Feb 8.

DOI:10.1111/cea.13838
PMID:33522024
Abstract
摘要

相似文献

1
Omalizumab in chronic inducible urticaria: A real-life study of efficacy, safety, predictors of treatment outcome and time to response.奥马珠单抗治疗慢性诱导性荨麻疹：一项关于疗效、安全性、治疗结果预测因素及起效时间的真实世界研究
Clin Exp Allergy. 2021 May;51(5):730-734. doi: 10.1111/cea.13838. Epub 2021 Feb 8.
2
Efficacy of omalizumab in chronic spontaneous urticaria associated with chronic inducible urticaria.奥马珠单抗治疗与慢性诱导性荨麻疹相关的慢性自发性荨麻疹的疗效
Ann Allergy Asthma Immunol. 2020 Oct;125(4):486-487. doi: 10.1016/j.anai.2020.06.011. Epub 2020 Jun 13.
3
The use of omalizumab for treatment-refractory chronic spontaneous urticaria in a West Australian outpatient cohort.在西澳大利亚门诊队列中，奥马珠单抗治疗难治性慢性自发性荨麻疹的应用。
Intern Med J. 2019 Apr;49(4):526-528. doi: 10.1111/imj.14245.
4
Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.奥马珠单抗对慢性自发性荨麻疹合并多种慢性诱导性荨麻疹患者有效。
Eur Ann Allergy Clin Immunol. 2021 Mar;53(2):91-93. doi: 10.23822/EurAnnACI.1764-1489.153. Epub 2021 Mar 1.
5
Efficacy of omalizumab for extracutaneous symptoms of chronic spontaneous urticaria.奥马珠单抗治疗慢性自发性荨麻疹皮肤外症状的疗效
Eur J Dermatol. 2021 Feb 1;31(1):86-87. doi: 10.1684/ejd.2020.3717.
6
Addition of omalizumab to antihistamine treatment in chronic urticaria: A real-world study in China.奥马珠单抗联合抗组胺药治疗慢性荨麻疹：一项中国的真实世界研究。
Ann Allergy Asthma Immunol. 2020 Aug;125(2):217-219. doi: 10.1016/j.anai.2020.04.026. Epub 2020 May 1.
7
Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study.奥马珠单抗单药或联合治疗慢性自发性荨麻疹的有效性和安全性的真实世界数据：一项回顾性队列研究。
J Dermatolog Treat. 2020 Mar;31(2):204-209. doi: 10.1080/09546634.2019.1589639. Epub 2019 Mar 7.
8
Characteristics of patients with chronic spontaneous urticaria showing early and complete responses to omalizumab.对奥马珠单抗表现出早期和完全反应的慢性自发性荨麻疹患者的特征
Ann Allergy Asthma Immunol. 2021 Sep;127(3):394-395. doi: 10.1016/j.anai.2021.05.031. Epub 2021 Jun 6.
9
Omalizumab for chronic spontaneous urticaria in "complex" patients: data from real-life clinical practice.奥马珠单抗用于“复杂”患者的慢性自发性荨麻疹：来自真实临床实践的数据
Drug Des Devel Ther. 2019 Sep 6;13:3181-3186. doi: 10.2147/DDDT.S214307. eCollection 2019.
10
Omalizumab in chronic inducible urticaria: A retrospective, real-life study.奥马珠单抗治疗慢性诱导性荨麻疹：一项回顾性、真实世界研究。
Ann Dermatol Venereol. 2021 Dec;148(4):262-265. doi: 10.1016/j.annder.2021.04.010. Epub 2021 Jul 8.

引用本文的文献

1
Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study.奥马珠单抗治疗慢性诱导性荨麻疹（CIndU）有效且安全：来自大型多国UCARE研究的真实世界数据。
Allergy. 2025 Feb;80(2):489-499. doi: 10.1111/all.16334. Epub 2024 Oct 8.
2
Solar Urticaria: An Ambispective Study in a Long-term Follow-up Cohort with Emphasis on Therapeutic Predictors and Outcomes.光致荨麻疹：长期随访队列中的一项双向研究，重点关注治疗预测因素和结局。
Acta Derm Venereol. 2024 Jan 8;104:adv25576. doi: 10.2340/actadv.v104.25576.
3
Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status.
奥马珠单抗治疗慢性自发性荨麻疹患者：现状的叙述性综述
Dermatol Ther (Heidelb). 2023 Nov;13(11):2573-2588. doi: 10.1007/s13555-023-01040-9. Epub 2023 Sep 30.
4
Efficacy of Different Dosing Regimens of IgE Targeted Biologic Omalizumab for Chronic Spontaneous Urticaria in Adult and Pediatric Populations: A Meta-Analysis.IgE靶向生物制剂奥马珠单抗不同给药方案对成人和儿童慢性自发性荨麻疹的疗效：一项荟萃分析
Healthcare (Basel). 2022 Dec 19;10(12):2579. doi: 10.3390/healthcare10122579.
5
Omalizumab on Chronic Spontaneous Urticaria and Chronic Inducible Urticaria: A Real-World Study of Efficacy and Predictors of Treatment Outcome.奥马珠单抗治疗慢性自发性荨麻疹和慢性诱导性荨麻疹：疗效的真实世界研究及治疗结局的预测因素。
J Korean Med Sci. 2022 Jul 11;37(27):e211. doi: 10.3346/jkms.2022.37.e211.
6
Disease Impact, Diagnostic Delay, and Unmet Medical Needs of Patients With Cholinergic Urticaria in German-Speaking Countries.德语国家胆碱能性荨麻疹患者的疾病影响、诊断延迟及未满足的医疗需求
Front Allergy. 2022 May 25;3:867227. doi: 10.3389/falgy.2022.867227. eCollection 2022.
7
Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria.奥马珠单抗治疗慢性自发性荨麻疹的疗效存在性别差异。
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211065870. doi: 10.1177/20587384211065870.
8
IgE and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance.慢性诱导性荨麻疹中的IgE与高亲和力IgE受体：发病机制及管理意义
Clin Transl Allergy. 2022 Feb 1;12(2):e12117. doi: 10.1002/clt2.12117. eCollection 2022 Feb.
9
Regulation of Trafficking and Signaling of the High Affinity IgE Receptor by FcεRIβ and the Potential Impact of FcεRIβ Splicing in Allergic Inflammation.FcεRIβ对高亲和力IgE受体的转运和信号传导的调节以及FcεRIβ剪接在过敏性炎症中的潜在影响。
Int J Mol Sci. 2022 Jan 12;23(2):788. doi: 10.3390/ijms23020788.
10
Expert consensus on the use of omalizumab in chronic urticaria in China.中国奥马珠单抗治疗慢性荨麻疹专家共识
World Allergy Organ J. 2021 Dec 5;14(11):100610. doi: 10.1016/j.waojou.2021.100610. eCollection 2021 Nov.